All bottled up.(biotechnology)(The prognosis for pharmaceutical corn in the Corn Belt is uncertain)(Industry Overview): An article from: Farm Journal
Book Details
Author(s)Andrew Burchett
PublisherFarm Journal Media
ISBN / ASINB0008D8PHO
ISBN-13978B0008D8PH4
AvailabilityAvailable for download now
Sales Rank15,158,373
MarketplaceUnited States 🇺🇸
Description
This digital document is an article from Farm Journal, published by Farm Journal Media on February 1, 2003. The length of the article is 1428 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the supplier: Meristem Therapeutics (Clermont-Ferrand, France) has decided not to plant pharmaceutical corn in the US due to a moratorium on the corn in the Midwest. The debate surrounding pharmaceutical corn is discussed.
Citation Details
Title: All bottled up.(biotechnology)(The prognosis for pharmaceutical corn in the Corn Belt is uncertain)(Industry Overview)
Author: Andrew Burchett
Publication:Farm Journal (Magazine/Journal)
Date: February 1, 2003
Publisher: Farm Journal Media
Volume: 127 Issue: 3 Page: 32(2)
Article Type: Industry Overview
Distributed by Thomson Gale
From the supplier: Meristem Therapeutics (Clermont-Ferrand, France) has decided not to plant pharmaceutical corn in the US due to a moratorium on the corn in the Midwest. The debate surrounding pharmaceutical corn is discussed.
Citation Details
Title: All bottled up.(biotechnology)(The prognosis for pharmaceutical corn in the Corn Belt is uncertain)(Industry Overview)
Author: Andrew Burchett
Publication:Farm Journal (Magazine/Journal)
Date: February 1, 2003
Publisher: Farm Journal Media
Volume: 127 Issue: 3 Page: 32(2)
Article Type: Industry Overview
Distributed by Thomson Gale

